J. L. Manzano Mozo

Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: a phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801).

R. Salazar, I. Durán, D. Castellano, 2013, European journal of cancer.

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study.

Edward J. Kim, P. Philip, J. Lacy, 2020, The lancet. Gastroenterology & hepatology.

Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.

M. Martín, F. Rivera, R. Pazo-Cid, 2017, European journal of cancer.

Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape

N. Mulet-Margalef, A. Calon, M. Jimeno, 2023, Cancers.